{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T21:13:17Z","timestamp":1770498797372,"version":"3.49.0"},"reference-count":41,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2001,12,21]],"date-time":"2001-12-21T00:00:00Z","timestamp":1008892800000},"content-version":"vor","delay-in-days":203,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Helicobacter"],"published-print":{"date-parts":[[2001,6]]},"abstract":"<jats:sec><jats:title>ABSTRACT<\/jats:title><\/jats:sec><jats:sec><jats:title>Aim.<\/jats:title><jats:p>The combination of a proton pump inhibitor (PPI) or ranitidine\u2010bismuth\u2010citrate (Rbc) and two antibiotics for 7\u201310\u00a0days are, at present, the preferred treatments in <jats:italic>Helicobacter pylori<\/jats:italic> eradication. However, therapies for fewer than 7\u00a0days have been scarcely evaluated and it is unknown whether the length of treatment can be shortened, without a lost of efficacy, if three instead of two antibiotics are used. The aim of our study was to evaluate the efficacy of Rbc plus three antibiotics for only 5 days in <jats:italic>H.\u00a0pylori<\/jats:italic> eradication.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods.<\/jats:title><jats:p>We prospectively studied 80 patients (34% duodenal ulcer, 66% functional dyspepsia) infected by <jats:italic>H.\u00a0pylori<\/jats:italic>. At endoscopy, biopsies were obtained for histological study and rapid urease test, and a <jats:sup>13<\/jats:sup>C\u2010urea breath test was carried out. Urea breath test was repeated 4 weeks after completing eradication treatment with Rbc [400\u00a0mg twice a day (bid)], amoxicillin (1\u00a0g bid), clarithromycin (500\u00a0mg bid) and metronidazole (500\u00a0mg bid). All drugs were administered together after breakfast and dinner for 5 days only, and no treatment was administered thereafter. Compliance with therapy was determined from the interrogatory and the recovery of empty envelopes of medications.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results.<\/jats:title><jats:p>In 79 out of the 80 patients, <jats:italic>H.\u00a0pylori<\/jats:italic> eradication success or failure was assessed after therapy (one patient was lost from follow\u2010up). All but one of these 79 patients took all the medications (one patient stopped treatment on the day 3 due to nausea\/vomiting). Per protocol eradication was achieved in 72\/78 (92%; 95% CI, 84\u201396%) and in 72\/80 (90%; 81\u201395%) by intention\u2010to\u2010treat. Therapy was more effective in patients with duodenal ulcer than in those with functional dyspepsia [100% (87\u2013100%) vs. 85% (73\u201392%) by intention\u2010to\u2010treat; <jats:italic>p<\/jats:italic>\u00a0&lt;\u00a0.05]. Adverse effects were described in ten patients (12%), and included the perception of a metallic taste (eight patients), nausea\/vomiting (two patients, one of them abandoned the treatment due to this), and diarrhea (two patients).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion.<\/jats:title><jats:p>The combination of Rbc, amoxicillin, clarithromycin and metronidazole for only 5 days represents a promising therapy for <jats:italic>H.\u00a0pylori<\/jats:italic> infection, due to its high efficacy, simple posology, low cost and excellent tolerance.<\/jats:p><\/jats:sec>","DOI":"10.1046\/j.1523-5378.2001.00023.x","type":"journal-article","created":{"date-parts":[[2003,3,11]],"date-time":"2003-03-11T23:22:30Z","timestamp":1047424950000},"page":"157-162","source":"Crossref","is-referenced-by-count":15,"title":["High Efficacy of Ranitidine Bismuth Citrate, Amoxicillin, Clarithromycin and Metronidazole Twice Daily for Only Five Days in <i>Helicobacter pylori<\/i> Eradication"],"prefix":"10.1111","volume":"6","author":[{"given":"Javier P.","family":"Gisbert","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Santiago","family":"Marcos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jose Luis","family":"Gisbert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jose Maria","family":"Pajares","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2001,12,21]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.41.1.8"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1746.1998.tb00537.x"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0025-7753(00)71237-1"},{"key":"e_1_2_6_5_2","first-page":"915","article-title":"The European 13C\u2010urea breath test for the detection of Helicobacter pylori","volume":"3","author":"Logan RPH","year":"1991","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.40.4.459"},{"key":"e_1_2_6_7_2","doi-asserted-by":"crossref","unstructured":"GisbertJP GonzalezL CalvetX GabrielR PajaresJM.Proton pump inhibitor clarithromycin and either amoxicillin or nitroimidazole: A meta\u2010analysis of eradication ofHelicobacter pylori.Aliment Pharmacol Ther2000;14:1319\u201328.","DOI":"10.1046\/j.1365-2036.2000.00844.x"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.1999.00542.x"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.1998.00405.x"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.1999.00530.x"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(97)80027-3"},{"key":"e_1_2_6_12_2","first-page":"1910","article-title":"The success of short\u2010course treatment regimens for Helicobacter pylori infections is strongly influenced by pre\u2010treatment antimicrobial susceptibility (Abstract","volume":"91","author":"Dworkin RJ","year":"1996","journal-title":"Am J Gastroenterol"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.1999.00493.x"},{"key":"e_1_2_6_14_2","first-page":"655","article-title":"Omeprazole plus 2 antibiotics for the eradication of H. pylori, are 5 days of treatment sufficient?","volume":"198","author":"Gisbert JP","year":"1998","journal-title":"Rev Clin Esp"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.1998.00290.x"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-5378.1998.08019.x"},{"key":"e_1_2_6_17_2","first-page":"a117","article-title":"The impact of clinical factors on the outcome of a new short term H. pylori eradication scheme (Abstract","volume":"45","author":"Treiber G","year":"1999","journal-title":"Gut"},{"key":"e_1_2_6_18_2","first-page":"A255","article-title":"Impact of treatment duration and metronidazole resistance on H. pylori cure with omeprazole, metronidazole, and clarithromycin (Abstract","volume":"112","author":"Peitz U","year":"1997","journal-title":"Gastroenterology"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.1358\/dot.1997.33.7.444742"},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-5378.1999.09038.x"},{"key":"e_1_2_6_21_2","doi-asserted-by":"publisher","DOI":"10.1097\/00042737-200012050-00003"},{"key":"e_1_2_6_22_2","doi-asserted-by":"crossref","unstructured":"GisbertJP GonzalezL CalvetX RoqueM GabrielR PajaresMJ.Helicobacter pylorieradication: Proton pump inhibitor versus ranitidine bismuth citrate plus two antibiotics for 1 week \u2013 A meta\u2010analysis of efficacy.Aliment Pharmacol Ther2000;14:1141\u201350.","DOI":"10.1046\/j.1365-2036.2000.00809.x"},{"key":"e_1_2_6_23_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1523-5378.1997.tb00052.x"},{"key":"e_1_2_6_24_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/42.3.309"},{"key":"e_1_2_6_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9270(98)00281-0"},{"key":"e_1_2_6_26_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.1999.00580.x"},{"key":"e_1_2_6_27_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.1999.00486.x"},{"key":"e_1_2_6_28_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.1999.00555.x"},{"key":"e_1_2_6_29_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.1999.3075_e.x"},{"key":"e_1_2_6_30_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.1999.00549.x"},{"key":"e_1_2_6_31_2","unstructured":"GisbertJP KhorramiS PajaresJM.Helicobacter pyloriresistance to metronidazole and clarithromycin in Spain. A systematic review.Med Clin (Barc)2001;116:111\u20136."},{"key":"e_1_2_6_32_2","unstructured":"GisbertJP HermidaC PajaresJM.Is twelve days of omeprazole amoxicillin and clarithromycin better than six days for treatingH. pyloriinfection in peptic ulcer and in non\u2010ulcer dyspepsia?Hepato\u2010Gastroenterology(In press)."},{"key":"e_1_2_6_33_2","doi-asserted-by":"publisher","DOI":"10.1097\/00042737-199908002-00005"},{"key":"e_1_2_6_34_2","first-page":"A84","article-title":"Duodenal ulcer and functional dyspepsia: different susceptibility of Helicobacter pylori to eradicating therapy (Abstract","volume":"112","author":"Catalano F","year":"1997","journal-title":"Gastroenterology"},{"key":"e_1_2_6_35_2","first-page":"A202","article-title":"Efficacy and tolerability of a seven\u2010day triple scheme with pantoprazole, amoxicillin and clarithromycin for eradication of Helicobacter pylori (Abstract","volume":"112","author":"Luna P","year":"1997","journal-title":"Gastroenterology"},{"key":"e_1_2_6_36_2","first-page":"A85","article-title":"Efficacy of PPI\u2010triple therapy in H. pylori positive patients with ulcer disease versus patients with non\u2010ulcer dyspepsia (Abstract","volume":"43","author":"Houben MHMG","year":"1998","journal-title":"Gut"},{"key":"e_1_2_6_37_2","first-page":"A92","article-title":"Different Helicobacter pylori eradication rates between non\u2010ulcer dyspepsia and peptic ulcer patients (Abstract","volume":"43","author":"Zullo A","year":"1998","journal-title":"Gut"},{"key":"e_1_2_6_38_2","first-page":"A275","article-title":"Efficacy of one week pantoprazole containing triple therapies for eradication of Helicobacter pylori (Abstract","volume":"45","author":"Tak\u00e1ts A","year":"1999","journal-title":"Gut"},{"key":"e_1_2_6_39_2","first-page":"A272","article-title":"Is PPI\u2010triple therapy of greater efficacy in peptic ulcer than in non\u2010ulcer dyspeptic patients (Abstract","volume":"45","author":"Katicic M","year":"1999","journal-title":"Gut"},{"key":"e_1_2_6_40_2","first-page":"A270","article-title":"Does the efficacy of eradication treatment with OCA\u20107 decrease in non\u2010ulcer gastroduodenal disease? (Abstract","volume":"45","author":"Borda F","year":"1999","journal-title":"Gut"},{"key":"e_1_2_6_41_2","doi-asserted-by":"publisher","DOI":"10.1097\/00045391-199901000-00005"},{"key":"e_1_2_6_42_2","first-page":"413","article-title":"Are one\u2010week anti\u2010H. pylori treatments more effective in patients with peptic ulcer disease (PUD) than in those with non\u2010ulcer dyspepsia (NUD)? A Meta\u2010Analysis (Abstract","volume":"59","author":"Huang JQ","year":"1998","journal-title":"Digestion"}],"container-title":["Helicobacter"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1523-5378.2001.00023.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1523-5378.2001.00023.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,28]],"date-time":"2023-09-28T10:43:03Z","timestamp":1695897783000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1046\/j.1523-5378.2001.00023.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,6]]},"references-count":41,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2001,6]]}},"alternative-id":["10.1046\/j.1523-5378.2001.00023.x"],"URL":"https:\/\/doi.org\/10.1046\/j.1523-5378.2001.00023.x","archive":["Portico"],"relation":{},"ISSN":["1083-4389","1523-5378"],"issn-type":[{"value":"1083-4389","type":"print"},{"value":"1523-5378","type":"electronic"}],"subject":[],"published":{"date-parts":[[2001,6]]}}}